WAM
GMED icon

Wealthspire Advisors (Maryland)’s Globus Medical GMED Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10
Closed – – 1067
2019
Q1 		$0 Buy
+10
New +$452 ﹤0.01% 2520
2018
Q1 		– Sell
-127
Closed -$5K – 2548
2017
Q4 		$5K Hold
127
– – ﹤0.01% 1828
2017
Q3 		$4K Sell
127
-99
-44% -$3.02K ﹤0.01% 1846
2017
Q2 		$7K Buy
+226
New +$7.1K ﹤0.01% 1656
2016
Q4 		– Sell
-395
Closed -$9K – 1784
2016
Q3 		$9K Sell
395
-60
-13% -$1.41K ﹤0.01% 1269
2016
Q2 		$11K Hold
455
– – ﹤0.01% 1180
2016
Q1 		$11K Hold
455
– – ﹤0.01% 1159
2015
Q4 		$13K Buy
+455
New +$11.4K ﹤0.01% 1114

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s GMED Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Globus Medical (GMED) in Q2 2019, closing a stake of 10 shares.

Wealthspire Advisors (Maryland) first reported a position in GMED in Q4 2015 and held it in 8 quarters. The position peaked at $13K in Q4 2015. 259 funds tracked by Wall St. Rank hold GMED as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Globus Medical position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 10 Globus Medical shares in Q2 2019.
  • Wealthspire Advisors (Maryland) first reported a position in Globus Medical in Q4 2015 and held it in 8 quarters.
  • Wealthspire Advisors (Maryland)'s Globus Medical position peaked at $13K in Q4 2015.
  • 259 funds tracked by Wall St. Rank held Globus Medical as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.